All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
| SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
| VLD / Velo3D, Inc.
|
|
|
|
|
|
|
|
| HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
| WE / WeWork Inc - Class A
|
|
|
|
|
|
|
|
| NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
| KVSB / Khosla Ventures Acquisition Co II - Class A
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US29335V1061 / Enjoy Technology, Inc.
|
|
|
|
|
|
|
|
| SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SQZ / SQZ Biotechnologies Co
|
|
|
|
|
|
|
|
| AMPL / Amplitude, Inc.
|
|
|
|
|
|
|
|
| S / SentinelOne, Inc.
|
|
|
|
|
|
|
|
| TOST / Toast, Inc.
|
|
|
|
|
|
|
|
| CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| SPGI / S&P Global Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| TWLO / Twilio Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
| PATH / UiPath Inc.
|
|
|
|
|
|
|
|
| BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
| FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
| LYFT / Lyft, Inc.
|
|
|
|
|
|
|
|
| NEWR / New Relic Inc
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
| OPRT / Oportun Financial Corporation
|
|
|
|
|
|
|
|
| OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| EVLO / Evelo Biosciences, Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DUOL / Duolingo, Inc.
|
|
|
|
|
|
|
|
| HOOD / Robinhood Markets, Inc.
|
|
|
|
|
|
|
|
| GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| EQRX / EQRx Inc
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
| HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| IONQ / IonQ, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
| PL / Planet Labs PBC
|
|
|
|
|
|
|
|
